Clinical Trials Logo

Filter by:
NCT ID: NCT01052896 Withdrawn - Clinical trials for Functional Dyspepsia

Gabapentin in Functional Dyspepsia Refractory to Proton Pump Inhibition

Start date: March 2010
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the effectiveness of gabapentin on symptom control in patients with defined functional dyspepsia refractory to conventional proton pump inhibitor therapy and to compare these effects to that of placebo.

NCT ID: NCT01052363 Withdrawn - Clinical trials for Central Nervous System Tumors

OXC401-PO1s/WVU 1309 - A Pilot Study of Fosbretabulin With Bevacizumab in Recurrent High-Grade Gliomas

Start date: January 2010
Phase: Phase 1
Study type: Interventional

Pilot Trial of CA4P with Avastin in Recurrent Gliomas

NCT ID: NCT01051947 Withdrawn - Clinical trials for Central Aortic Pressure

Impact of Nebivolol on Central Aortic Pressure

Start date: December 2009
Phase: N/A
Study type: Interventional

A randomized, cross-over, single-blind study to compare the effects of nebivolol and metoprolol on central aortic pressure and peripheral brachial pressure in patients with stable cardiovascular disease.

NCT ID: NCT01050192 Withdrawn - Prematurity Clinical Trials

Nutritional Content of Breast Milk From Mothers of Premies

Start date: December 2009
Phase: N/A
Study type: Observational

The purpose of this study is to determine the correlation, if any, between the nutritional content of breast milk pumped by the mothers of very low birth weight (VLBW) infants in the neonatal intensive care unit (NICU) and the nutritional value they are actually receiving in a 24 hour period, since as a practical matter, these may not be the same.

NCT ID: NCT01049178 Withdrawn - Atopic Asthma Clinical Trials

Randomized Controlled Trial of Silymarin in Asthma

Start date: September 2010
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to determine if intake of the antioxidant enzyme inducer, silymarin, will improve lung function and symptom scores in participants with asthma.

NCT ID: NCT01048996 Withdrawn - Clinical trials for Acute Respiratory Distress Syndrome

Genetic Variability and Biomarkers in Children With Acute Lung Injury

BALI
Start date: October 2009
Phase: N/A
Study type: Observational

Acute Lung Injury (ALI) and the more severe Acute Respiratory Distress Syndrome (ARDS) are a significant problem in Pediatric Intensive Care Units, affecting up to 16 of every 1000 children admitted to these units. These disorders carry with them high mortality rates as well as numerous long-term effects for the surviving children. As the effects of these diseases have significant social and economic ramifications for affected children and their families, research on the development of ALI/ARDS could significantly change how physicians understand the disease and treat patients. There are a wide range of problems which make certain PICU patients more likely to develop either ALI or ARDS. This research aims to determine which of these children are at the greatest risk for ALI/ARDS by examining differences in plasma biomarkers and in DNA of a large number of PICU patients. We are hypothesizing that significant differences in the level of specific plasma biomarkers or in the frequency of specific DNA variants exist in children who develop ALI/ARDS.

NCT ID: NCT01048177 Withdrawn - Vulvodynia Clinical Trials

A Trial of Intravesical Therapy for Interstitial Cystitis in Patients With Generalized Vulvodynia

VV/IC
Start date: December 2012
Phase: Phase 2
Study type: Interventional

In order to investigate whether the pain in women with vulvodynia may represent bladder origin pain, we will be performing a diagnostic test for interstitial cystitis (IC) in women with generalized vulvodynia. Those women with a positive test for IC, we will be performing a series of bladder treatments (instillations) for IC and checking symptoms throughout the trial to see if significant relief of vulvar pain can be obtained through treatment for IC.

NCT ID: NCT01048086 Withdrawn - Neuroblastoma Clinical Trials

90Y DOTA/Retinoic Acid for Neuroblastoma and Neuroendocrine Tumor (NET)

Start date: June 2009
Phase: Phase 2
Study type: Interventional

This study is for patients with neuroblastoma or a neuroendocrine tumor who have not been able to have standard therapy or have failed the first-line therapy. The purpose of this study is to assess the safety and effectiveness of the combination of retinoic acid and Onalta (Y-90-DOTA-tyr3-Octreotide) in treating neuroblastoma and neuroendocrine tumors.

NCT ID: NCT01047137 Withdrawn - Chronic Urticaria Clinical Trials

Response of Urticaria to Stress Intervention

Start date: July 2010
Phase: N/A
Study type: Interventional

Several studies have shown a relationship between psychological stress and chronic urticaria (hives). The primary objective of this study is to evaluate the effect psychological stress intervention has on chronic urticaria.

NCT ID: NCT01047072 Withdrawn - Clinical trials for Systemic Scleroderma

Low-Dose Conditioning Followed by Donor Stem Cell Transplant in Treating Patients With Severe Systemic Sclerosis

Start date: n/a
Phase: Phase 2
Study type: Interventional

The purpose of the study is to see how well reduced intensity conditioning followed by a stem cell transplant from a donor (allogeneic) works in treating patients with severe systemic sclerosis. In an allogeneic stem cell transplant procedure, stem cells are taken from a healthy donor and transplanted into the patient. Stem cells can be donated by a family member or an unrelated donor who is a complete tissue type match.